May 04, 2026 07:30 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jolt to TMC! Supreme Court rejects plea challenging central staff deployment at Bengal counting centres | Bangladesh MP warns of refugee crisis if BJP wins West Bengal polls | Diplomatic row: Bangladesh summons Indian envoy over Himanta Biswa Sarma remarks | Supreme Court grants Pawan Khera anticipatory bail in case over allegations against Himanta Biswa Sarma's wife | ‘Not necessary to humiliate me with arrest’: Pawan Khera to SC over remarks on Himanta Biswa Sarma’s wife | ‘Let’s not choose for people capable of choosing’: Supreme Court to Centre on teen pregnancy termination | I-PAC co-founder Vinesh Chandel gets bail after Bengal polls conclude | Exit Polls Give Bengal to BJP—But One Survey Begs to Differ | Big defence push: Rajnath Singh to hold high-stakes talks with Italy’s Defence Minister | “Voting without fear”: PM Modi hails record turnout in West Bengal polls
India UK

India, UK join forces on new £8 million scientific research

| @indiablooms | Jul 28, 2020, at 05:40 am

New Delhi/IBNS: Britain and India are deepening their existing scientific research collaboration with five new projects to tackle anti-microbial resistance (AMR) that could lead to important advances in the global fight against antibiotic-resistant bacteria and genes.

The funding awards were announced by Lord (Tariq) Ahmad of Wimbledon, Minister of State for South Asia and the Commonwealth, ahead of a virtual visit to India on 28 July.

India is a major producer of antimicrobials in the pharmaceutical industry global supply chain, and the research projects aim to develop a better understanding of how waste from antimicrobial manufacturing could be inadvertently fuelling AMR.

Subject to clearances, the five projects are planned for September 2020. The UK is contributing £4 million from the UK Research and Innovation Fund for International Collaboration, and India is matching this with its own resources (£8m in total).

Lord (Tariq) Ahmad said: “The UK has already partnered with India’s Serum Institute to manufacture the vaccine for Covid-19, if clinical trials are successful, with plans to distribute to a billion people across the developing world. But there is more we can do together to tackle urgent global health issues in the world. Our thriving research and innovation partnerships will benefit people in the UK and India, and beyond.”

Philip Barton, High Commissioner to India, said: “The UK is India’s second biggest research partner, with joint research expected to be worth £400 million by next year. This huge investment enables us to work closely together on global health challenges such as the search for a Covid-19 vaccine. Today’s announcement is another demonstration of our excellent research relationship and will strengthen the important fight against anti-microbial resistance.”

During the visit to India, Minister Lord (Tariq) Ahmad will chair a virtual roundtable with senior Indian and UK-based stakeholders on cold-chain technologies that are critical for the effective transport of vaccines, ensuring they successfully reach their final destination.

Other elements of the Minister’s visit include meeting with Indian Minister of State for External Affairs and Parliamentary Affairs, Minister Muraleedharan, to discuss a number of subjects including multilateral cooperation, a meeting with Gujarati Chief Minister Vijay Rupani, discussions with regional governments and others on opportunities in wind power and a virtual tour of a UK funded solar plant in Rajasthan.

(Image: Pixabay)


 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.